GLP-3 RT peptide vial by Priority Aminos

GLP-3 RT is supplied as a lyophilized vial for laboratory research, formulated for studies of triple GIP/GLP-1/glucagon receptor agonism. Available in 10mg, 20mg, and 30mg strengths with lot-coded traceability and tamper-evident packaging.

✓

Independently Lab-Tested

Third-party purity verification — current lot per strength

Strength	Lot #	Content	Purity	Tested
10mg	PA-2025-034	11.20mg	99.440%	Aug 1, 2025
20mg	PA-2026-001	19.2mg (95.8% of label)	99.70%	Nov 4, 2025
30mg	PA-2025-017	31.51mg; 28.79mg	99.776%; 99.884%	Jul 7, 2025

GLP-3 RT

Fast U.S. Shipping
Lot-Coded Vials
Tamper-Evident Packaging
Secure Checkout

Independently Lab-Tested

Third-party purity verification — current lot per strength

Strength	Lot #	Content	Purity	Tested
10mg	PA-2025-034	11.20mg	99.440%	Aug 1, 2025
20mg	PA-2026-001	19.2mg (95.8% of label)	99.70%	Nov 4, 2025
30mg	PA-2025-017	31.51mg; 28.79mg	99.776%; 99.884%	Jul 7, 2025

Research Use Only • Not for human or veterinary use

Select an option to see how many 210 Priority Points you earn.

Clear

Description

Overview

GLP-3 RT is a synthetic peptide studied in laboratory research as a triple GIP/GLP-1/glucagon receptor agonist, part of the retatrutide-class research family exploring combined incretin and glucagon receptor signaling. It is investigated alongside related multi-agonist compounds such as GLP-2 TZ (a dual GIP/GLP-1 agonist) within the broader incretin-pathway literature. Supplied as a lyophilized powder, available in 10mg, 20mg, and 30mg strengths, with lot-coded traceability and tamper-evident packaging carried through fulfillment.

Research Focus

Triple GIP/GLP-1/glucagon receptor agonism studies
Multi-agonist incretin signaling pathway research
Comparative research within the retatrutide-class peptide family
Energy homeostasis and metabolic pathway investigations
In vitro receptor-binding assay applications

GLP-3 RT Specifications

Product Type: Research Peptide

Format: Lyophilized powder, sealed vial

Available Strengths: 10mg, 20mg, 30mg

Traceability: Lot-coded identification

Packaging: Tamper-evident

Category: Triple Incretin Receptor Agonist (GIP/GLP-1/Glucagon)

Storage & Handling

Store lyophilized powder at −20°C for long-term storage
Once reconstituted, refrigerate at 2–8°C and use within your protocol’s stability window
Protect from light and minimize repeated freeze–thaw cycles
Follow institutional handling procedures and PPE requirements
Dispose of materials per applicable institutional guidelines

Frequently Asked Questions

What is GLP-3 RT studied for?

GLP-3 RT is investigated in laboratory literature as a triple GIP/GLP-1/glucagon receptor agonist, part of the retatrutide-class research family exploring combined incretin and glucagon receptor signaling.

What form is it supplied in?

A lyophilized (freeze-dried) powder in a sealed glass vial, ready for reconstitution per your lab’s protocol.

Is a Certificate of Analysis available for this lot?

Yes — third-party HPLC results are published above for each available strength, including content and purity figures per lot.

How is it packaged and tracked?

Every vial carries an internal lot code tied to our traceability log, plus tamper-evident sealing maintained from fulfillment through delivery.

Is this for human or veterinary use?

No. This product is sold strictly for laboratory research use by qualified researchers, and is not a drug, dietary supplement, or medical device.

Ordering & Fulfillment

Orders are prepared from lot-tracked inventory and shipped in tamper-evident packaging with tracking information.

Additional information

Size	10mg, 20mg, 30mg